Health-related quality of life after anonymous nondirected living liver donation: A multicenter collaboration |
| |
| Authors: | Muhammad H. Raza Whitney E. Jackson Angela Dell Li Ding James Shapiro Elizabeth A. Pomfret Yuri Genyk Linda Sher Juliet Emamaullee |
| |
| Affiliation: | 1. Keck School of Medicine, University of Southern California, Los Angeles, California, USA;2. Department of Gastroenterology and Hepatology, University of Colorado, Aurora, Colorado, USA;3. Department of Surgery, University of Alberta, Edmonton, Alberta, Canada;4. Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA;5. Department of Surgery, University of Colorado, Aurora, Colorado, USA;6. Keck School of Medicine, University of Southern California, Los Angeles, California, USA Division of Hepatobiliary and Abdominal Transplant Surgery, Department of Surgery, University of Southern California, Los Angeles, California, USA |
| |
| Abstract: | Literature on living nondirected liver donation is sparse. The purpose of this study was to assess health-related quality of life (HR-QOL) in anonymous nondirected living liver donors (ND-LLDs). ND-LLDs at 3 centers: University of Alberta (n = 12), University of Colorado (n = 12), and University of Southern California (n = 12), were surveyed. Thirty donors (83%) responded to the Donor Quality of Life (USC DQLS) and Short-Form 36 (SF-36). Most respondents (n = 15, 50%) donated their left lateral segment, 27% right lobe, and 23% left lobe. The majority were female (67%) and mean age was 38.9 ± 11.2 years at donation. Median follow-up was 1.1 (interquartile range 0.4-3.3) years. Approximately 37% had previously donated a kidney. Eleven experienced ≥1 postoperative complication, with only 1 Clavien-Dindo IIIb. Most reported minimal impact on school or work performance, all felt positive or neutral about their overall health since donation, and none expressed postdonation regrets. No donor reported impacts on health insurability, and 3 of 4 respondents attempting to purchase life insurance postdonation were successful. ND-LLD SF-36 outcomes were similar to US population norms. Overall, ND-LLDs demonstrated acceptable HR-QOL after donation and are appropriate candidates for partial liver donation. Based on evaluation of donation impact, consideration should be given to postdonation support strategies. |
| |
| Keywords: | clinical research/practice donors and donation: living liver transplantation/hepatology liver transplantation: living donor quality of life (QOL) |
|
|
